Comerica Securities’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-400
Closed -$47.8K 1065
2022
Q4
$47.8K Buy
+400
New +$47.8K ﹤0.01% 718